Furthermore, we confirmed that CRC in individuals with MLH1 and MSH2 gPVs often develops without visible precursor lesions, whereas in individuals with MSH6 and PMS2 gPVs, significantly more visible precursor lesions are detected. The gene discussed is MLH1; the disease is colorectal carcinoma.